MultiPlan Corporation (MPLN)
NYSE: MPLN · IEX Real-Time Price · USD
0.281
-0.034 (-10.89%)
At close: Jul 2, 2024, 4:00 PM
0.288
+0.007 (2.42%)
After-hours: Jul 2, 2024, 7:52 PM EDT
MultiPlan Market Cap
MultiPlan has a market cap or net worth of $181.01 million as of July 2, 2024. Its market cap has decreased by -86.11% in one year.
Market Cap
181.01M
Enterprise Value
4.66B
1-Year Change
-86.11%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since February 14, 2020, MultiPlan's market cap has decreased from $1.05B to $181.01M, a decrease of -82.78%. That is a compound annual growth rate of -33.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 203.10M | -78.29% |
| Dec 29, 2023 | 935.30M | 27.25% |
| Dec 30, 2022 | 735.00M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 407.42% |
| Feb 14, 2020 | 1.05B | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 266.19M |
| Black Diamond Therapeutics | 262.14M |
| CVRx, Inc. | 258.93M |
| Cibus | 256.65M |
| Viemed Healthcare | 254.28M |
| Adaptimmune Therapeutics | 249.08M |
| Pulmonx | 246.09M |
| Mersana Therapeutics | 245.95M |